EphB2 was shown to be a downstream transcriptional target of the Notch pathway and promoted inflammatory cytokine and chemokine secretion from hepatocytes; accordingly, inhibition of hepatocyte EphB2 expression in a mouse MASH model reduced inflammatory cell recruitment and attenuated fibrosis (65). The gene discussed is EPHB2; the disease is metabolic dysfunction-associated steatohepatitis.